Diabetes CGM Developments We continue to progress ... Act”), including but not limited to statements related to Trinity Biotech’s cash position, financial resources and potential for future ...

DUBLIN, May 15, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable ...

Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable ...

The additional liquidity will support both the continued development of Trinity Biotech’s innovative continuous glucose monitoring (CGM) technology and the Company Trinity Biotech’s patented ...

The additional liquidity will support both the continued development of Trinity Biotech’s innovative continuous glucose monitoring (CGM) technology and the Company Trinity Biotech’s patented ...

Diabetes CGM Developments We continue to progress the development ... Act of 1995 (the “Reform Act”), including but not limited to statements related to Trinity Biotech’s cash position, financial ...